Blurbs

Atlas Arteria (MAQAF) was Downgraded to a Hold Rating at Macquarie

Myles has an average return of 6.1% when recommending Atlas Arteria.

According to TipRanks.com, Myles is ranked #2618 out of 7923 analysts.

Currently, the analyst consensus on Atlas Arteria is a Strong Buy with an average price target of $5.18.

See today’s best-performing stocks on TipRanks >>

Atlas Arteria’s market cap is currently $4.82B and has a P/E ratio of 39.12.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Atlas Arteria is a global toll-road investor created out of the reorganisation of Macquarie Infrastructure Group in 2010. The firm’s main asset is a 31% stake in Autoroutes Paris-Rhin-Rhone, or APRR. APRR owns concessions to toll more than 2,300 kilometres of motorways in eastern France, most ending late 2035.

Read More on MAQAF:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
Videos

Latest News Feed